British American Tobacco Industries p.l.c. (BTI) vs Orchestra BioMed (OBIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Orchestra BioMed (OBIO) has outperformed British American Tobacco Industries p.l.c. (BTI) over the past year, gaining 107.3% versus a gain of 3.7%. Over five years, BTI leads with a +49.3% price change compared with -42.5% for OBIO. British American Tobacco Industries p.l.c. is the larger company by market cap ($119.23 billion vs $344.4 million), about 346.2 times the size.
British American Tobacco Industries p.l.c. pays a dividend yielding 4.42%, while Orchestra BioMed does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BTI | OBIO |
|---|---|---|
| Share price | $55.43 | $5.73 |
| Market cap | $119.23B | $344.40M |
| 1-day change | +2.84% | +1.24% |
| YTD return | -4.80% | +36.39% |
| 1-year return | +3.69% | +107.33% |
| 5-year return | +49.31% | -42.54% |
| P/E ratio (TTM) | 14.21 | — |
| Forward P/E | 10.58 | — |
| EPS (TTM) | $3.90 | $-0.86 |
| Dividend yield | 4.42% | 0.00% |
| Annual dividend | $2.45 | $0.00 |
| 52-week high | $67.30 | $6.50 |
| 52-week low | $49.88 | $2.78 |
| Distance from 52-week high | -17.64% | -11.85% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +27.06% | +116.93% |
| Average volume | 4.58M | 299.24K |
| Shares outstanding | 2.15B | 60.11M |
| Employees | 47,797 | 86 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- British American Tobacco Industries p.l.c. is about 346.2 times larger than Orchestra BioMed by market value ($119.23B vs $344.40M).
- OBIO has outperformed BTI by 103.6 percentage points over the past year.
- British American Tobacco Industries p.l.c. offers a meaningfully higher dividend yield (4.42% vs 0.00%).
About British American Tobacco Industries p.l.c.
BTI stock →British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the United States, Europe, Latin America, Canada, the Asia-Pacific, the Middle East, Central Asia, Caucasus, and Africa.
Health Care · Medicinal Chemicals and Botanical Products · 47,797 employees
About Orchestra BioMed
OBIO stock →Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States.
Health Care · Medicinal Chemicals and Botanical Products · 86 employees
BTI vs OBIO FAQ
Which is bigger, British American Tobacco Industries p.l.c. or Orchestra BioMed?
British American Tobacco Industries p.l.c. (BTI) is larger, with a market capitalization of $119.23B compared with $344.40M for Orchestra BioMed (OBIO).
Which stock has performed better over the past year, BTI or OBIO?
OBIO returned +107.33% over the past 12 months, compared with +3.69% for BTI (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, British American Tobacco Industries p.l.c. or Orchestra BioMed?
British American Tobacco Industries p.l.c. pays a dividend yielding 4.42%, while Orchestra BioMed does not currently pay a regular dividend.
Are British American Tobacco Industries p.l.c. and Orchestra BioMed in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.